OIs remain common in settings where ART is not widely available, in patients with undiagnosed HIV disease, and in patients who fail therapy due to drug resistance, nonadherence, or intolerance
Guidelines on preventing and treating OIs in patients with HIV are published by the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America (Management Guidelines)[CDC OI] and the European AIDS Clinical Society (Management Guidelines)[EACS]
The authors also direct Spanish-speaking clinicians to the guideline of the Grupo de Estudio de Sida (GESIDA) on the treatment of OIs (Management Guidelines)[GESIDA OI]
Action required
Login now to access all of your entitled content
or